Bilateral PA Medical Treatment — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Medical therapy with a mineralocorticoid receptor antagonist (spironolactone or eplerenone) is recommended for bilateral primary aldosteronism (bilateral adrenal hyperplasia) — surgery is reserved for unilateral disease (aldosterone-producing adenoma)
Primary aldosteronism subtype determines treatment: (1) UNILATERAL aldosterone-producing adenoma (APA): laparoscopic adrenalectomy is curative (BP normalises in 40-60%, improves in >90%); (2) BILATERAL adrenal hyperplasia (BAH): medical therapy with MRA (spironolactone 25-50 mg, or eplerenone if gynaecomastia) — surgery is NOT appropriate as removing one adrenal would not address the bilateral problem. AVS is the gold standard for lateralisation (distinguishing unilateral from bilateral disease) — CT alone is insufficient because: (1) non-functioning adrenal incidentalomas are common (3-5% of CT scans) and may coexist with PA; (2) aldosterone-producing adenomas may be too small for CT detection (<1 cm); (3) bilateral macronodular hyperplasia may mimic bilateral adenomas. The 2024 ESC Hypertension Guidelines recommend AVS before surgical decision-making.
Reference: ESC (2024): Hypertension Guidelines; Endocrine Society PA Guidelines